Analyzing the market taxonomy by application reveals that cardiology consumes 46 % of 2023 global revenues, driven by rapid growth in percutaneous coronary interventions and electrophysiology mapping, while vascular surgery accounts for 31 %, propelled by aortic and peripheral endograft delivery, and urology, gastroenterology, and otolaryngology share the residual 23 %, leveraging specialized hydrophilic wires for ureteral, biliary, and eustachian procedures. Cardiology’s share benefits from high procedure volumes and stringent deliverability requirements that justify premium pricing, whereas vascular applications prioritize kink resistance and large-diameter support, segmenting procurement toward reinforced nitinol constructions. The smaller specialty clusters exhibit fragmented purchasing but higher margin potential, as clinicians accept customized tip shapes and diameters (<0.025 in) that general surgeons seldom request, enabling suppliers to extract incremental revenue from catalog extensions rather than entirely new R&D programs.